Covestus

Deal Type
Private Equity

Initial Investment
July 2024

Sector
Healthcare

Fund
Private Equity
Buyout Fund

Status
Current

Covestus is a fast-growing consumer healthcare group. The business is undertaking an ambitious buy and build strategy acquiring established healthcare brands with strong clinical credentials and clear opportunities to improve brand recognition, product distribution or to pursue new product development opportunities. Covestus is creating a diversified group of high performing consumer health assets, with a particular focus on niche, high growth businesses which are often out of scope to the main mid-market consolidators.

Its existing portfolio includes Probio7, a leading gut health supplement brand, Sweatguard, a clinically proven solution for hyperhidrosis, and Dentyl, a leading mouthwash brand.

Covestus

Covestus brings a differentiated approach to consumer healthcare by combining clinical credibility with modern beauty-led brand building. The Group is focused on solving highly personal, often chronic conditions through products that are both effective and beautifully designed.

This fusion of science, design and consumer insight positions Covestus to meet the growing demand for self-care solutions that deliver real outcomes while resonating emotionally with consumers. With Maven’s support, the business is well placed to accelerate innovation, expand internationally and build a portfolio of category leading brands.

Tim Wright, Executive Chair at Covestus

Meet the lead executive(s)

Tom Purkis
Tom Purkis

Partner

Andrew Ferguson
Andrew Ferguson

Partner

Jonathan Oliver
Jonathan Oliver

Investment Director